Axsome Therapeutics Inc AXSM shares are trading higher Monday after the company received proposed labeling from the U.S. Food and Drug Administration for its treatment of major depressive disorder.
Axsome Therapeutics filed a Form 8-K with the U.S. Securities and Exchange Commission showing that it received proposed labeling for its AXS-05 product candidate with respect to its New Drug Application. The company is reviewing the proposed labeling and said it will reply to the FDA to secure the final labeling agreement.
Axsome Therapeutics is a biopharmaceutical company developing novel therapies for central nervous system conditions that have limited treatment options.
AXS-05 is the company's novel, oral, investigational NMDA receptor antagonist with multimodal activity being developed for major depressive disorder, Alzheimer's disease agitation and smoking cessation.
See Also: Why Alibaba Stock Is Rising Today
AXSM Price Action: Axsome Therapeutics has traded between $74.10 and $19.38 over a 52-week period.
The stock was up 46% at $35.70 at press time, according to data from Benzinga Pro.
Photo: fernando zhiminaicela from Pixabay.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.